Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CURRNASDAQ:MXCTNASDAQ:OABINASDAQ:TRVG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCURRCurrenc Group$0.81+21.6%$0.82$0.33▼$7.08$31.17M-0.492.76 million shs3.18 million shsMXCTMaxCyte$2.18-0.9%$2.37$2.00▼$5.20$234.12M1.28616,813 shs444,799 shsOABIOmniAb$1.74+2.4%$1.58$1.22▼$4.96$207.63M-0.02651,764 shs510,588 shsTRVGTrivago N.V. ADS$3.77+4.4%$4.22$1.60▼$5.83$253.81M1.4295,817 shs39,359 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCURRCurrenc Group+21.63%+62.01%+35.82%-48.10%+81,489,900.00%MXCTMaxCyte-0.91%+0.46%-5.22%-19.56%-44.39%OABIOmniAb+2.35%+8.07%+37.01%-23.68%-53.60%TRVGTrivago N.V. ADS+4.43%-1.57%-6.68%-15.66%+87.56%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCURRCurrenc GroupN/AN/AN/AN/AN/AN/AN/AN/AMXCTMaxCyte2.9221 of 5 stars3.53.00.00.03.01.70.6OABIOmniAb3.0973 of 5 stars3.51.00.00.02.73.31.3TRVGTrivago N.V. ADS2.583 of 5 stars3.15.00.00.02.70.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCURRCurrenc Group 3.50Strong Buy$3.50329.50% UpsideMXCTMaxCyte 3.00Buy$7.50244.04% UpsideOABIOmniAb 3.00Buy$7.00302.30% UpsideTRVGTrivago N.V. ADS 2.25Hold$4.7325.33% UpsideCurrent Analyst Ratings BreakdownLatest CURR, MXCT, TRVG, and OABI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/12/2025OABIOmniAbBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$6.00 ➝ $6.005/5/2025TRVGTrivago N.V. ADSSusquehannaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$3.50 ➝ $5.505/1/2025TRVGTrivago N.V. ADSB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$4.00 ➝ $5.504/28/2025TRVGTrivago N.V. ADSUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$3.10 ➝ $3.40(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCURRCurrenc Group$46.44M0.82N/AN/A($0.90) per share-0.91MXCTMaxCyte$38.63M6.01N/AN/A$1.95 per share1.12OABIOmniAb$26.39M8.05N/AN/A$2.37 per share0.73TRVGTrivago N.V. ADS$498.74M0.53$0.06 per share60.65$3.04 per share1.24Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCURRCurrenc Group-$39.47MN/A0.00∞N/AN/AN/A-38.11%7/14/2025 (Estimated)MXCTMaxCyte-$41.06M-$0.40N/AN/AN/A-110.92%-19.90%-17.24%8/5/2025 (Estimated)OABIOmniAb-$62.03M-$0.58N/AN/AN/A-229.11%-21.37%-18.84%8/6/2025 (Estimated)TRVGTrivago N.V. ADS-$25.64MN/A51.57188.50N/A-4.82%0.52%0.33%7/29/2025 (Estimated)Latest CURR, MXCT, TRVG, and OABI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/29/2025Q2 2025TRVGTrivago N.V. ADS-$0.07N/AN/AN/AN/AN/A5/20/2025Q1 2025CURRCurrenc Group-$0.04-$0.13-$0.09-$0.13$10.50 million$10.06 million5/8/2025Q1 2025OABIOmniAb-$0.17-$0.17N/A-$0.17$4.49 million$4.15 million5/7/2025Q1 2025MXCTMaxCyte-$0.10-$0.10N/A-$0.10$9.05 million$10.39 million4/14/2025Q4 2024CURRCurrenc Group-$0.04-$0.70-$0.66-$0.70$10.50 million$11.07 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCURRCurrenc GroupN/AN/AN/AN/AN/AMXCTMaxCyteN/AN/AN/AN/AN/AOABIOmniAbN/AN/AN/AN/AN/ATRVGTrivago N.V. ADSN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCURRCurrenc GroupN/A0.610.61MXCTMaxCyteN/A12.2311.58OABIOmniAbN/A4.704.70TRVGTrivago N.V. ADSN/A3.213.21Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCURRCurrenc Group56.01%MXCTMaxCyte68.81%OABIOmniAb72.08%TRVGTrivago N.V. ADS4.50%Insider OwnershipCompanyInsider OwnershipCURRCurrenc Group43.30%MXCTMaxCyte3.30%OABIOmniAb8.60%TRVGTrivago N.V. ADS6.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCURRCurrenc Group246.53 million26.38 millionN/AMXCTMaxCyte80106.42 million102.90 millionOptionableOABIOmniAb7122.14 million111.63 millionOptionableTRVGTrivago N.V. ADS71070.31 million65.74 millionOptionableCURR, MXCT, TRVG, and OABI HeadlinesRecent News About These Companiestrivago (NASDAQ:TRVG) Sees Large Drop in Short InterestJune 17, 2025 | marketbeat.comCompagnie Lombard Odier SCmA Grows Stock Position in trivago (NASDAQ:TRVG)June 13, 2025 | marketbeat.comTrivago watched its revenue forecast plummet from $1 billion to nearly zero—so the company tapped a set of former interns to turn it aroundJune 13, 2025 | msn.comUniversal Beteiligungs und Servicegesellschaft mbH Invests $628,000 in trivago (NASDAQ:TRVG)June 4, 2025 | marketbeat.comTrivago (TRVG) Is Attractively Priced Despite Fast-paced MomentumMay 29, 2025 | zacks.comTrivago: Some countries shunning US travelMay 28, 2025 | travelmole.comTtrivago N.V. Announces Annual General Meeting of ShareholdersMay 22, 2025 | globenewswire.comtrivago Announces 2025 Shareholder MeetingMay 22, 2025 | tipranks.comTrivago’s millennial CEO says he never had a career plan: ‘I just followed where the energy was’May 13, 2025 | finance.yahoo.comTrivago’s millennial CEO says he never had a career plan: ‘I just followed where the energy was’May 13, 2025 | msn.com2 Intriguing Internet Stocks to Buy Now: TRVG, UPWKMay 9, 2025 | zacks.comTrivago N.V. ADS (TRVG) Is Up 42.86% in One Week: What You Should KnowMay 9, 2025 | zacks.comTrivago (TRVG) Shows Fast-paced Momentum But Is Still a Bargain StockMay 9, 2025 | zacks.comDemystifying trivago: Insights From 5 Analyst ReviewsMay 6, 2025 | benzinga.comAnalysts Offer Insights on Communication Services Companies: trivago (TRVG) and Meta Platforms (META)May 2, 2025 | theglobeandmail.comB. Riley Securities Upgrades trivago N.V. - Depositary Receipt () (TRVG)May 2, 2025 | msn.comtrivago NV (TRVG) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic InvestmentsMay 1, 2025 | finance.yahoo.comtrivago N.V.: trivago Delivers 22% Revenue Growth and Raises Full-Year GuidanceApril 30, 2025 | finanznachrichten.deWhy These 15 Communication Services Stocks Are up the Most So Far in 2025April 30, 2025 | insidermonkey.comTrivago's Turnaround Is Kicking In as Growth AcceleratesApril 30, 2025 | skift.comTrivago N.V. (TRVG) Q1 2025 Earnings Conference Call TranscriptApril 30, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Companies to Buy on This Early Cycle RecoveryBy Gabriel Osorio-Mazilli | June 3, 2025View 3 Companies to Buy on This Early Cycle RecoveryThe Market’s Silent Warning: What Bonds and Gold RevealBy Gabriel Osorio-Mazilli | June 6, 2025View The Market’s Silent Warning: What Bonds and Gold RevealAutoNation: Growth Engines Make It an Undervalued Stock By Jeffrey Neal Johnson | June 29, 2025View AutoNation: Growth Engines Make It an Undervalued Stock As Gold Surges, Albemarle Stock May Be the Next to PopBy Gabriel Osorio-Mazilli | June 10, 2025View As Gold Surges, Albemarle Stock May Be the Next to PopWhy Visa's Innovation Engine Keeps It a Top Portfolio PickBy Jeffrey Neal Johnson | June 6, 2025View Why Visa's Innovation Engine Keeps It a Top Portfolio PickCURR, MXCT, TRVG, and OABI Company DescriptionsCurrenc Group NASDAQ:CURR$0.81 +0.14 (+21.63%) As of 06/30/2025 04:00 PM EasternCurrenc Group, Inc. engages in operating a fintech banking platform. It operates through the following segments: Remittance Services, Sales of Airtime, and Other Services. The company is headquartered in Singapore.MaxCyte NASDAQ:MXCT$2.18 -0.02 (-0.91%) As of 06/30/2025 04:00 PM EasternMaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.OmniAb NASDAQ:OABI$1.74 +0.04 (+2.35%) As of 06/30/2025 04:00 PM EasternOmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.Trivago N.V. ADS NASDAQ:TRVG$3.77 +0.16 (+4.43%) As of 06/30/2025 04:00 PM Easterntrivago N.V., together with its subsidiaries, operates a hotel and accommodation search platform in the United States, Germany, the United Kingdom, Canada, Japan, and internationally. It offers an online meta-search for hotels and accommodation through online travel agencies, hotel chains, and independent hotels. The company provides travel search for different types of accommodations, such as hotels, vacation rentals, and apartments; and enable advertiser access through website and apps. In addition, it offers access to its platform through various localized websites and apps in various languages. The company was incorporated in 2005 and is headquartered in Düsseldorf, Germany. trivago N.V. operates as a subsidiary of Expedia Lodging Partner Services Sarl. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher The Top Insider Sells From Q2: Buy, Sell, or Hold? 5 High-Yielding ETFs to Buy and Hold Forever Why BigBear.ai Could Rally 100% and Catch Palantir Soon Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Alphabet’s Waymo and Services Beginning to Feel the Pressure? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
